View in EDS

Flecainide to prevent atrial arrhythmia after patent foramen ovale closure, Rationale and design of the randomized AFLOAT study.

Saved in:
Bibliographic Details
Title: Flecainide to prevent atrial arrhythmia after patent foramen ovale closure, Rationale and design of the randomized AFLOAT study.
Authors: Hauguel-Moreau M; Université de Versailles-Saint Quentin, INSERM U1018, CESP, ACTION Study Group, Department of Cardiology, Ambroise Paré Hospital (AP-HP), 92100 Boulogne, France., Guedeney P; Sorbonne Université, ACTION Study Group, INSERM UMRS1166, ICAN-Institute of CardioMetabolism and Nutrition, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), 75013 Paris, France., Dauphin C; Department of Cardiology and Cardiovascular Diseases, Clermont-Ferrand University Hospital, 63000 Clermont-Ferrand, France., Auffret V; University Hospital Pontchaillou, Cardiology and Vascular Disease Department, CIC-IT 804, Rennes 1 University, Signal and Image Processing Laboratory (LTSI), INSERM U1099, 35000 Rennes, France., Marijon E; Cardiology Department, European Georges Pompidou Hospital, 75015 Paris, France., Aldebert P; Cardiology Division, Hôpital La Timone, 13000 Marseille, France., Clerc JM; Cardiology Department, Centre Hospitalier Universitaire de Tours, 37000 Tours, France., Beygui F; CHU de la Côte de Nacre, Département de Cardiologie, 14000 Caen, France., Elbaz M; Department of Cardiology, Institute CARDIOMET, CHU-Toulouse, 31000 Toulouse, France., Khalil WA; Institut Mitovasc, University of Angers, UMR CNRS 6015-INSERMU1083, 49000 Angers, France., Da Costa A; Service de cardiologie, Hôpital Nord, Université Jean-Monnet, CHU de Saint-Étienne, 42000 Saint-Étienne, France., Macia JC; Montpellier University Hospital, UFR de Médecine, Université Montpellier 1, Department of Cardiology, 371, avenue du Doyen-Gaston-Giraud, 34000 Montpellier 5, France., Elhadad S; Service de Cardiologie, Centre hospitalier de Marne-la-Vallée, 77600 Jossigny, France., Cayla G; Cardiology department, Nimes University Hospital, Montpellier University, ACTION group, 34000 Nimes, France., Brugier D; Sorbonne Université, ACTION Study Group, INSERM UMRS1166, ICAN-Institute of CardioMetabolism and Nutrition, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), 75013 Paris, France., Silvain J; Sorbonne Université, ACTION Study Group, INSERM UMRS1166, ICAN-Institute of CardioMetabolism and Nutrition, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), 75013 Paris, France., Hammoudi N; Sorbonne Université, ACTION Study Group, INSERM UMRS1166, ICAN-Institute of CardioMetabolism and Nutrition, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), 75013 Paris, France., Duthoit G; Sorbonne Université, ACTION Study Group, INSERM UMRS1166, ICAN-Institute of CardioMetabolism and Nutrition, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), 75013 Paris, France., Vicaut E; ACTION Study Group, Unité de Recherche Clinique, Hopital Lariboisière, (APHP), Université Paris-Diderot Paris 7, 75010 Paris, France., Montalescot G; Sorbonne Université, ACTION Study Group, INSERM UMRS1166, ICAN-Institute of CardioMetabolism and Nutrition, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), 75013 Paris, France.
Corporate Authors: ACTION Study Group
Source: European heart journal. Cardiovascular pharmacotherapy [Eur Heart J Cardiovasc Pharmacother] 2024 May 04; Vol. 10 (3), pp. 184-189.
Publication Type: Journal Article; Clinical Trial Protocol
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101669491 Publication Model: Print Cited Medium: Internet ISSN: 2055-6845 (Electronic) NLM ISO Abbreviation: Eur Heart J Cardiovasc Pharmacother Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38216511
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Flecainide to prevent atrial arrhythmia after patent foramen ovale closure, Rationale and design of the randomized AFLOAT study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hauguel-Moreau+M%22">Hauguel-Moreau M</searchLink>; Université de Versailles-Saint Quentin, INSERM U1018, CESP, ACTION Study Group, Department of Cardiology, Ambroise Paré Hospital (AP-HP), 92100 Boulogne, France.<br /><searchLink fieldCode="AU" term="%22Guedeney+P%22">Guedeney P</searchLink>; Sorbonne Université, ACTION Study Group, INSERM UMRS1166, ICAN-Institute of CardioMetabolism and Nutrition, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), 75013 Paris, France.<br /><searchLink fieldCode="AU" term="%22Dauphin+C%22">Dauphin C</searchLink>; Department of Cardiology and Cardiovascular Diseases, Clermont-Ferrand University Hospital, 63000 Clermont-Ferrand, France.<br /><searchLink fieldCode="AU" term="%22Auffret+V%22">Auffret V</searchLink>; University Hospital Pontchaillou, Cardiology and Vascular Disease Department, CIC-IT 804, Rennes 1 University, Signal and Image Processing Laboratory (LTSI), INSERM U1099, 35000 Rennes, France.<br /><searchLink fieldCode="AU" term="%22Marijon+E%22">Marijon E</searchLink>; Cardiology Department, European Georges Pompidou Hospital, 75015 Paris, France.<br /><searchLink fieldCode="AU" term="%22Aldebert+P%22">Aldebert P</searchLink>; Cardiology Division, Hôpital La Timone, 13000 Marseille, France.<br /><searchLink fieldCode="AU" term="%22Clerc+JM%22">Clerc JM</searchLink>; Cardiology Department, Centre Hospitalier Universitaire de Tours, 37000 Tours, France.<br /><searchLink fieldCode="AU" term="%22Beygui+F%22">Beygui F</searchLink>; CHU de la Côte de Nacre, Département de Cardiologie, 14000 Caen, France.<br /><searchLink fieldCode="AU" term="%22Elbaz+M%22">Elbaz M</searchLink>; Department of Cardiology, Institute CARDIOMET, CHU-Toulouse, 31000 Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Khalil+WA%22">Khalil WA</searchLink>; Institut Mitovasc, University of Angers, UMR CNRS 6015-INSERMU1083, 49000 Angers, France.<br /><searchLink fieldCode="AU" term="%22Da+Costa+A%22">Da Costa A</searchLink>; Service de cardiologie, Hôpital Nord, Université Jean-Monnet, CHU de Saint-Étienne, 42000 Saint-Étienne, France.<br /><searchLink fieldCode="AU" term="%22Macia+JC%22">Macia JC</searchLink>; Montpellier University Hospital, UFR de Médecine, Université Montpellier 1, Department of Cardiology, 371, avenue du Doyen-Gaston-Giraud, 34000 Montpellier 5, France.<br /><searchLink fieldCode="AU" term="%22Elhadad+S%22">Elhadad S</searchLink>; Service de Cardiologie, Centre hospitalier de Marne-la-Vallée, 77600 Jossigny, France.<br /><searchLink fieldCode="AU" term="%22Cayla+G%22">Cayla G</searchLink>; Cardiology department, Nimes University Hospital, Montpellier University, ACTION group, 34000 Nimes, France.<br /><searchLink fieldCode="AU" term="%22Brugier+D%22">Brugier D</searchLink>; Sorbonne Université, ACTION Study Group, INSERM UMRS1166, ICAN-Institute of CardioMetabolism and Nutrition, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), 75013 Paris, France.<br /><searchLink fieldCode="AU" term="%22Silvain+J%22">Silvain J</searchLink>; Sorbonne Université, ACTION Study Group, INSERM UMRS1166, ICAN-Institute of CardioMetabolism and Nutrition, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), 75013 Paris, France.<br /><searchLink fieldCode="AU" term="%22Hammoudi+N%22">Hammoudi N</searchLink>; Sorbonne Université, ACTION Study Group, INSERM UMRS1166, ICAN-Institute of CardioMetabolism and Nutrition, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), 75013 Paris, France.<br /><searchLink fieldCode="AU" term="%22Duthoit+G%22">Duthoit G</searchLink>; Sorbonne Université, ACTION Study Group, INSERM UMRS1166, ICAN-Institute of CardioMetabolism and Nutrition, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), 75013 Paris, France.<br /><searchLink fieldCode="AU" term="%22Vicaut+E%22">Vicaut E</searchLink>; ACTION Study Group, Unité de Recherche Clinique, Hopital Lariboisière, (APHP), Université Paris-Diderot Paris 7, 75010 Paris, France.<br /><searchLink fieldCode="AU" term="%22Montalescot+G%22">Montalescot G</searchLink>; Sorbonne Université, ACTION Study Group, INSERM UMRS1166, ICAN-Institute of CardioMetabolism and Nutrition, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), 75013 Paris, France.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22ACTION+Study+Group%22">ACTION Study Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101669491%22">European heart journal. Cardiovascular pharmacotherapy</searchLink> [Eur Heart J Cardiovasc Pharmacother] 2024 May 04; Vol. 10 (3), pp. 184-189.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial Protocol
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101669491 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2055-6845 (Electronic) <i>NLM ISO Abbreviation: </i>Eur Heart J Cardiovasc Pharmacother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38216511
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/ehjcvp/pvad100
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 184
    Titles:
      – TitleFull: Flecainide to prevent atrial arrhythmia after patent foramen ovale closure, Rationale and design of the randomized AFLOAT study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hauguel-Moreau M
      – PersonEntity:
          Name:
            NameFull: Guedeney P
      – PersonEntity:
          Name:
            NameFull: Dauphin C
      – PersonEntity:
          Name:
            NameFull: Auffret V
      – PersonEntity:
          Name:
            NameFull: Marijon E
      – PersonEntity:
          Name:
            NameFull: Aldebert P
      – PersonEntity:
          Name:
            NameFull: Clerc JM
      – PersonEntity:
          Name:
            NameFull: Beygui F
      – PersonEntity:
          Name:
            NameFull: Elbaz M
      – PersonEntity:
          Name:
            NameFull: Khalil WA
      – PersonEntity:
          Name:
            NameFull: Da Costa A
      – PersonEntity:
          Name:
            NameFull: Macia JC
      – PersonEntity:
          Name:
            NameFull: Elhadad S
      – PersonEntity:
          Name:
            NameFull: Cayla G
      – PersonEntity:
          Name:
            NameFull: Brugier D
      – PersonEntity:
          Name:
            NameFull: Silvain J
      – PersonEntity:
          Name:
            NameFull: Hammoudi N
      – PersonEntity:
          Name:
            NameFull: Duthoit G
      – PersonEntity:
          Name:
            NameFull: Vicaut E
      – PersonEntity:
          Name:
            NameFull: Montalescot G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 05
              Text: 2024 May 04
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2055-6845
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: European heart journal. Cardiovascular pharmacotherapy
              Type: main
ResultId 1